Type 2 diabetes mellitus
Conditions
Interventions
CSII group:CSII group received human insulin with an insulin pump
MDI group:Patients in the MDI group were treated with pre-meal insulin, and long-acting insulin at bedtime.
Sponsors
the First People's Hospital, Xuzhou, Jiangsu
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with newly diagnosed type 2 diabetes, according to WHO diagnostic criteria (1999), who had not received previous antihyperglycaemic therapy, were enrolled from our hospital between January, 2017, and January,2018. The patients, aged 18-60 years, had levels of HbAlc great than or equal to 9.0%.
Exclusion criteria
Exclusion criteria: Exclusion criteria were circulating islet cell antibodies; diabetic ketosis; recent acute illness; or concomitant chronic disease, including kidney, liver, and cardiovascular disease. T2DM patients who were treated with oral hypoglycemic, hypolipidemic and/or antihypertensive agents were also excluded to avoid the possible confounding effects of medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum betatrophin level; | — |
Secondary
| Measure | Time frame |
|---|---|
| ß-cell function;Remission rate;Serum glucose levels;HbA1c; | — |
Countries
China
Contacts
Public ContactWang Zhaoling
the First People's Hospital, Xuzhou, Jiangsu
Outcome results
None listed